0001209191-19-015904.txt : 20190304
0001209191-19-015904.hdr.sgml : 20190304
20190304181550
ACCESSION NUMBER: 0001209191-19-015904
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190228
FILED AS OF DATE: 20190304
DATE AS OF CHANGE: 20190304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CAMPBELL KIM
CENTRAL INDEX KEY: 0001183827
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38112
FILM NUMBER: 19655691
MAIL ADDRESS:
STREET 1: 3300 HYLAND AVE
CITY: COSTA MESA
STATE: CA
ZIP: 92626
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athenex, Inc.
CENTRAL INDEX KEY: 0001300699
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 431985966
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
BUSINESS PHONE: 716-898-8625
MAIL ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20131223
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC
DATE OF NAME CHANGE: 20040817
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-28
0
0001300699
Athenex, Inc.
ATNX
0001183827
CAMPBELL KIM
C/O ATHENEX, INC.
1001 MAIN STREET, SUITE 600
BUFFALO
NY
14203
1
0
0
0
Stock Option (Right to Buy)
9.00
2017-10-17
2025-10-17
Common Stock
48000
48000
D
Stock Option (Right to Buy)
11.00
2027-06-13
Common Stock
30000
30000
D
Stock Option (Right to Buy)
13.17
2019-02-28
4
A
0
15000
0.00
A
2029-02-28
Common Stock
15000
15000
D
This option vests in four equal annual installments beginning on June 13, 2018.
This option vests in four equal annual installments beginning on February 28, 2020.
/s/ Teresa Bair, Attorney-in-Fact
2019-03-04